David M. Knott »

Iovance Biotherapeutics shares owned by David M. Knott

Quarter-by-quarter ownership of Iovance Biotherapeutics (IOVA) shares owned by David M. Knott from 13F filings

Historical chart of David M. Knott investment in Iovance Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Iovance Biotherapeutics held by David M. Knott consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Iovance Biotherapeutics by David M. Knott

Quarter filed Position value Share count Share price at filing
2021-09-30 $99k 4.0k 24.75

More positions owned by David M. Knott

Calumet Specialty Products Partners Common
Apollo Global Management Common
Alphabet Inc-Cl C Common (GOOG)
Fortress Trans & Infrastructure Inv Common
Greenidge Generation Holdings Common Put Option
Ligand Pharmaceuticals Incorporated Common (LGND)
Upland Software Common (UPLD)
Coliseum Acquisition Corp Common (MITA)
Kadmon Holdings Common
Midwest Holding Common
Greenidge Generation Holdings Common
Coliseum Acquisition Corp. Wts Common (MITAW)
African Gold Acquistion Corp. Warrants Common
Twelve Seas Investment Company II Common (TWLV)
Pfizer Common (PFE)

View all positions for David M. Knott

Top funds holding Iovance Biotherapeutics

Perceptive Advisors
Vanguard Group
MHR Fund Management
BlackRock
BlackRock
State Street Corporation
Soleus Capital Management
T. Rowe Price Investment Management
Geode Capital Management
Artisan Partners Limited Partnership
Balyasny Asset Management
Long Focus Capital Management
Principal Financial Group
T. Rowe Price Associates
Palo Alto Investors

View all funds holding Iovance Biotherapeutics